| Literature DB >> 29853784 |
Mariana Mendes-Braz1, Joilson O Martins1.
Abstract
Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycaemia and high morbidity worldwide. The detrimental effects of hyperglycaemia include an increase in the oxidative stress (OS) response and an enhanced inflammatory response. DM compromises the ability of the liver to regenerate and is particularly associated with poor prognosis after ischaemia-reperfusion (I/R) injury. Considering the growing need for knowledge of the impact of DM on the liver following a surgical procedure, this review aims to present recent publications addressing the effects of DM (hyperglycaemia) on OS and the inflammatory process, which play an essential role in I/R injury and impaired hepatic regeneration after liver surgery.Entities:
Mesh:
Year: 2018 PMID: 29853784 PMCID: PMC5964489 DOI: 10.1155/2018/2456579
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Figure 1Mechanisms of OS in the promotion of liver damage and impaired regeneration after liver surgery in association with DM. The illustration shows the molecular events subsequent to the surgical procedure performed on the diabetic liver, which leads to a significant increase of ROS, inducing liver injury and regeneration. PH, partial hepatectomy; I/R, ischaemia-reperfusion; O2−, superoxide anion; HSP, heat shock protein; NF-κB, nuclear factor kappa B; Nrf2, nuclear factor (erythroid-derived 2)-like-2 factor; H2O2, hydrogen peroxide; •OH, hydroxyl radical.
Figure 2Inflammatory mechanisms underlying the promotion of liver damage and impaired regeneration after liver surgery in association with DM. The illustration shows the molecular events subsequent to the surgical procedure performed on the diabetic liver, inducing the participation of inflammatory cells and consequent cytokine production, leading to liver injury and regeneration. TA, adipose tissue; AGE, advanced glycation end products; RAGE, receptor for AGE; IL-6, interleukin-6; IL-10, interleukin-10; TNF-α, tumour necrosis factor-α; MCP-1, monocyte chemoattractant protein-1; JAK, Janus kinase; STAT3, signal transducer and activator of transcription 3; CHOP, C/EBP homologous protein; NF-κB, nuclear factor kappa B; COX-2, cyclooxygenase-2; PH, partial hepatectomy; I/R, ischaemia-reperfusion.